These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 18664271)

  • 21. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.
    Fuchs NV; Loewer S; Daley GQ; Izsvák Z; Löwer J; Löwer R
    Retrovirology; 2013 Oct; 10():115. PubMed ID: 24156636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues.
    Stauffer Y; Theiler G; Sperisen P; Lebedev Y; Jongeneel CV
    Cancer Immun; 2004 Feb; 4():2. PubMed ID: 14871062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
    Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y
    J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotype analysis of the human endogenous retrovirus locus HERV-K(HML-2.HOM) and its evolutionary implications.
    Mayer J; Stuhr T; Reus K; Maldener E; Kitova M; Asmus F; Meese E
    J Mol Evol; 2005 Nov; 61(5):706-15. PubMed ID: 16211423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
    Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
    J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
    J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues.
    Schmitt K; Heyne K; Roemer K; Meese E; Mayer J
    Mob DNA; 2015; 6():4. PubMed ID: 25750667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant origin and interspecies transmission of a HERV-K(HML-2)-related primate retrovirus with a novel RNA transport element.
    Williams ZH; Imedio AD; Gaucherand L; Lee DC; Mostafa SM; Phelan JP; Coffin JM; Johnson WE
    Elife; 2024 Jul; 13():. PubMed ID: 39037763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 Binding Sites in Long Terminal Repeat 5Hs (LTR5Hs) of Human Endogenous Retrovirus K Family (HML-2 Subgroup) Play Important Roles in the Regulation of LTR5Hs Transcriptional Activity.
    Liu M; Jia L; Li H; Liu Y; Han J; Wang X; Li T; Li J; Zhang B; Zhai X; Yu C; Li L
    Microbiol Spectr; 2022 Aug; 10(4):e0048522. PubMed ID: 35867400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human endogenous retrovirus HERV-K(HML-2) env expression is not associated with markers of immunosenescence.
    Marttila S; Nevalainen T; Jylhävä J; Kananen L; Jylhä M; Hervonen A; Hurme M
    Exp Gerontol; 2017 Oct; 97():60-63. PubMed ID: 28774724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites.
    Montesion M; Williams ZH; Subramanian RP; Kuperwasser C; Coffin JM
    Retrovirology; 2018 Aug; 15(1):57. PubMed ID: 30126415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1.
    Bhardwaj N; Montesion M; Roy F; Coffin JM
    Viruses; 2015 Mar; 7(3):939-68. PubMed ID: 25746218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of human endogenous retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers.
    Grabski DF; Ratan A; Gray LR; Bekiranov S; Rekosh D; Hammarskjold ML; Rasmussen SK
    J Pediatr Surg; 2021 Feb; 56(2):286-292. PubMed ID: 32682541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues.
    Burn A; Roy F; Freeman M; Coffin JM
    PLoS Biol; 2022 Oct; 20(10):e3001826. PubMed ID: 36256614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines.
    Tatkiewicz W; Dickie J; Bedford F; Jones A; Atkin M; Kiernan M; Maze EA; Agit B; Farnham G; Kanapin A; Belshaw R
    Mob DNA; 2020; 11():9. PubMed ID: 32055257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human endogenous retrovirus encoded protease potentially cleaves numerous cellular proteins.
    Rigogliuso G; Biniossek ML; Goodier JL; Mayer B; Pereira GC; Schilling O; Meese E; Mayer J
    Mob DNA; 2019; 10():36. PubMed ID: 31462935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human endogenous retrovirus HERV-K14 families: status, variants, evolution, and mobilization of other cellular sequences.
    Flockerzi A; Burkhardt S; Schempp W; Meese E; Mayer J
    J Virol; 2005 Mar; 79(5):2941-9. PubMed ID: 15709013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermutation of an ancient human retrovirus by APOBEC3G.
    Lee YN; Malim MH; Bieniasz PD
    J Virol; 2008 Sep; 82(17):8762-70. PubMed ID: 18562521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls.
    Wildschutte JH; Ram D; Subramanian R; Stevens VL; Coffin JM
    Retrovirology; 2014 Aug; 11():62. PubMed ID: 25112280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human endogenous retrovirus HERV-K(HML-2) activity in prostate cancer is dominated by a few loci.
    Goering W; Schmitt K; Dostert M; Schaal H; Deenen R; Mayer J; Schulz WA
    Prostate; 2015 Dec; 75(16):1958-71. PubMed ID: 26384005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.